-

02:53:21 PM

BSX Stock News

BSX - Boston Scientific Corp.

10/02/23 6:30 AM

NYSE : BSX

earnings

Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results

Boston Scientific Corporation will webcast its conference call discussing financial results and business highlights for the third quarter ending September 30, 2023, on Thursday, October 26, 2023, at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan,...

RHEA-AI

neutral

09/27/23 8:15 AM

NYSE : BSX

Boston Scientific: Encouraging and Empowering Tomorrow’s STEM Pioneers

NORTHAMPTON, MA / ACCESSWIRE / September 27, 2023 / At Boston Scientific, we strive to advance science for life, which includes inspiring the next generation of STEM professionals who will help shape the future of health care. Using a combination of hands-on experiences and classroom education, our

RHEA-AI

positive

09/21/23 8:15 AM

NYSE : BSX

What Is the Boston Scientific Foundation?

NORTHAMPTON, MA / ACCESSWIRE / September 21, 2023 / Boston ScientificAs a leader in health care, Boston Scientific is dedicated to creating healthier communities in a wealth of ways, including large-scale programs like Close the Gap that help increase health equity in the U.S. and global corporate

RHEA-AI

very positive

09/21/23 6:45 AM

NYSE : CVS, BSX

management

CVS Health appoints Michael F. Mahoney to its Board of Directors

CVS Health Corporation has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation, a global medical technology leader, to serve on the Board of Directors of CVS Health, effective November 1.. "Mike's focus throughout his career– to drive improvements in health outcomes and increase access to care–...

RHEA-AI

very positive

09/19/23 7:00 AM

NYSE : BSX

acquisition

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept ® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic...

RHEA-AI

neutral

09/06/23 4:00 PM

NYSE : BSX

fda approval

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device

Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device.

RHEA-AI

neutral

09/05/23 8:30 AM

NYSE : BSX

earnings

Boston Scientific Announces 2023 Investor Day Meeting and Conference Call Discussing Third Quarter 2023 Results

Boston Scientific Corporation will host a meeting with the investor community to review its financial goals and long-term growth strategies on Wednesday, September 20, 2023, between 8:30 a.m. and 1:00 p.m. ET. "Our results in the first half of 2023 exceeded our expectations and demonstrated the strength of our...

RHEA-AI

neutral

08/27/23 6:13 AM

NYSE : BSX

ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints

Boston Scientific Corporation today announced positive 12- month results from the pivotal ADVENT clinical trial of the FARAPULSE™ Pulsed Field Ablation System*, a nonthermal treatment in which electric fields selectively ablate heart tissue in patients with atrial fibrillation.

RHEA-AI

neutral

08/08/23 4:01 PM

NYSE : BSX

fda approval

Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System

Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration approval for the POLARx™ Cryoablation System. The new system, which is indicated...

RHEA-AI

neutral

08/03/23 8:00 AM

NYSE : BSX

Building Disability Inclusion

NORTHAMPTON, MA / ACCESSWIRE / August 3, 2023 / Boston ScientificOriginally published by CAREERS & the disABLEDBird & MacDonald Advocate for Inclusion at Boston ScientificHAVING DEVOTED HER ENTIRE CAREER TO DIVERSITY, EQUITY, AND INCLUSION (DEI) WORK, SHANI BIRD HAS LED DEI EFFORTS AT

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next